{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:03:40Z","timestamp":1789707820160,"version":"4.0.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.trecan.2024.07.006","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T20:23:36Z","timestamp":1723667016000},"page":"876-879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["CFTR and colorectal cancer susceptibility: an urgent need for further studies"],"prefix":"10.1016","volume":"10","author":[{"given":"S.","family":"Spelier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Derksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hofland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Beekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Yetkin-Arik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2024.07.006_bb0005","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science (80-.)"},{"key":"10.1016\/j.trecan.2024.07.006_bb0010","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jcf.2016.01.002","article-title":"Colonoscopic screening shows increased early incidence and progression of adenomas in cystic fibrosis","volume":"15","author":"Niccum","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.trecan.2024.07.006_bb0015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jcf.2022.10.001","article-title":"The risk of colorectal cancer in individuals with mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene: an English population-based study","volume":"22","author":"Birch","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.trecan.2024.07.006_bb0020","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/ijc.33431","article-title":"Cystic fibrosis F508del carriers and cancer risk: results from the UK Biobank","volume":"148","author":"Shi","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.trecan.2024.07.006_bb0025","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/j.gastro.2017.12.012","article-title":"Cystic fibrosis colorectal cancer screening consensus recommendations","volume":"154","author":"Hadjiliadis","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trecan.2024.07.006_bb0030","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200265","article-title":"Colorectal cancer (CRC) as a multifactorial disease and its causal correlations with multiple signaling pathways","volume":"40","author":"Wan","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.trecan.2024.07.006_bb0035","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1016\/j.cell.2021.11.031","article-title":"Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps","volume":"184","author":"Chen","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2024.07.006_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/wsbm.1370","article-title":"Cancer and inflammation","volume":"9","author":"Munn","year":"2017","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"10.1016\/j.trecan.2024.07.006_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105614","article-title":"Analysis of CFTR gene expression as an immunological and prognostic biomarker in pan-cancers","volume":"146","author":"Wang","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.trecan.2024.07.006_bb0050","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1038\/onc.2015.483","article-title":"CFTR is a tumor suppressor gene in murine and human intestinal cancer","volume":"35","author":"Than","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2024.07.006_bb0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jcmgh.2017.11.013","article-title":"Cftr modulates Wnt\/\u03b2-catenin signaling and stem cell proliferation in murine intestine","volume":"5","author":"Strubberg","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.trecan.2024.07.006_bb0060","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/cbin.11260","article-title":"Promoter hypermethylation of the CFTR gene as a novel diagnostic and prognostic marker of breast cancer","volume":"44","author":"Liu","year":"2020","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.trecan.2024.07.006_bb0065","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jnci\/djs481","article-title":"Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States","volume":"105","author":"Maisonneuve","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.trecan.2024.07.006_bb0070","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jcf.2021.07.004","article-title":"Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study","volume":"21","author":"Archangelidi","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.trecan.2024.07.006_bb0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13023-023-02671-z","article-title":"Increasing incidence rate of breast cancer in cystic fibrosis-relationship between pathogenesis, oncogenesis and prediction of the treatment effect in the context of worse clinical outcome and prognosis of cystic fibrosis due to estrogens","volume":"18","author":"Stastna","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.trecan.2024.07.006_bb0080","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1073\/pnas.1914912117","article-title":"Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions","volume":"117","author":"Miller","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2024.07.006_bb0085","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1126\/scitranslmed.aad8278","article-title":"Supplementary materials for characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis","volume":"8","author":"Dekkers","year":"2016","journal-title":"Sci. Transl. Med."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803324001468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803324001468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T15:24:08Z","timestamp":1728401048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803324001468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2405803324001468"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2024.07.006","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CFTR and colorectal cancer susceptibility: an urgent need for further studies","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2024.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}